miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. (Q38859854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Zhen Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ying-Yi Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Bao-Hua Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fei Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hong-Yu Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

26 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

9395-9403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113407%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-015-3679-5

18 February 2020

exact match

0 references

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Mir-33 regulates cell proliferation and cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

The proto-oncogene Pim-1 is a target of miR-33a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

XB130, a new adaptor protein, regulates expression of tumor suppressive microRNAs in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3679-5

MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

21 January 2018

1 reference

12 December 2020

Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies

1 reference

12 December 2020

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review).

1 reference

12 December 2020

Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin

1 reference

12 December 2020

Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.

1 reference

12 December 2020